Kezar Life Sciences, Inc.
Develops small molecule therapies for immune-mediated, liver, and oncologic disorders.
KZR | US
Overview
Corporate Details
- ISIN(s):
- US49372L2097
- LEI:
- Country:
- United States of America
- Address:
- 4000 SHORELINE COURT, SUITE 300, 94080 SOUTH SAN FRANCISCO
- Website:
- https://kezarlifesciences.com/
- Sector:
- Manufacturing
Description
Kezar Life Sciences is a clinical-stage biotechnology company focused on the discovery and development of novel, first-in-class small molecule therapeutics. The company advances unique protein-targeting approaches designed to inhibit multiple disease-driving cellular pathways and address the limitations of available treatments. Its development pipeline focuses on creating breakthrough therapies for immune-mediated diseases, liver disease, and oncologic disorders.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Kezar Life Sciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Kezar Life Sciences, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Kezar Life Sciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
